WEBSTER, Texas, Oct. 21 /PRNewswire/ — IDEV Technologies,
Incorporated (IDEV), an innovative leader in the development and
commercialization of minimally invasive medical technologies, today
announced another step in the implementation of its strategy to
expand its product line for treating patients with peripheral
vascular disease with the addition of two longer stents to its
SUPERA product line. The initial uses of the newly introduced 180mm
and 200mm stents occurred in August of this year, followed by a
full European market launch at the recent European Society of
Vascular Surgery meeting held this past September, in
SUPERA stents are well known for their radial strength and
flexibility that results from the unique wire interwoven nitinol
design, which also provides high resistance to kinking/fracturing.
The new 180mm and 200mm sizes are designed for the treatment
of long lesions in patients with peripheral vascular disease.
“We are very pleased with the acceptance of these new longer
stents. Our goal is to provide the broadest and most
effective line of products for treating patients with peripheral
vascular disease. The successful launch of these additional
SUPERA sizes moves us closer to reaching that goal and achieves our
objective of launching multiple new products in Europe this year,”
stated Christopher M. Owens, President and CEO of IDEV.
The launch of these devices follows the recent introduction of
the SUPERA VERITAS™ Peripheral Vascular System, an easy to
use, reliable and more precise delivery system developed to deliver
the SUPERA stent.
Peter Haarbrink, MD, a leading interventional radiologist
affiliated with Canisius Wilhelmina Ziekenhuis (CWZ), a large
general and teaching hospital located in Nijmegen, The Netherlands,
said, “The availability of these new sizes has given me even more
options for treating patients with peripheral vascular disease.
The unique and exceptional st